Altimmune, Inc. Quarterly Depreciation in USD from Q3 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Altimmune, Inc. quarterly/annual Depreciation history and growth rate from Q3 2012 to Q1 2024.
  • Altimmune, Inc. Depreciation for the quarter ending March 31, 2024 was $107K, a 14.4% decline year-over-year.
  • Altimmune, Inc. annual Depreciation for 2023 was $477K, a 3.25% decline from 2022.
  • Altimmune, Inc. annual Depreciation for 2022 was $493K, a 23.3% increase from 2021.
  • Altimmune, Inc. annual Depreciation for 2021 was $400K, a 33.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $107K -$18K -14.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $125K +$25K +25% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $400K $100K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $400K $132K +$51.7K +64.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $348K $100K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $348K $68.5K +$7.79K +12.8% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $340K $100K +$40.5K +68.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $300K $79.8K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $100K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $60.7K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $59.5K -$1.77K -2.89% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $61.3K +$36.2K +145% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q1 2018 $25.1K +$12.1K +93.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 $38.4K $13K -$24.7K -65.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $63.1K -$47.3K -$80.1K -244% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $143K $32.2K -$2.77K -7.91% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $146K $40.4K +$3.75K +10.2% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $142K $37.7K +$595 +1.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $142K $32.8K -$3.88K -10.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 $145K $35K -$2.12K -5.71% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $148K $36.7K +$479 +1.32% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $147K $37.1K -$2.83K -7.09% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $150K $36.7K -$6.75K -15.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-14
Q3 2014 $157K $37.1K -$7.47K -16.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $164K $36.2K -$5.65K -13.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $170K $39.9K -$12.7K -24.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $182K $43.4K Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $44.6K -$27.9K -38.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $41.9K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $52.6K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q3 2012 $72.5K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.